Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReFacto AF in Pediatric Severe Hemophilia A
NCT00914459Phase 4Completed
- Sponsor
- Pfizer
- Start
- Dec 2009
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 4 trial of moroctocog alfa in hemophilia A, sponsored by Pfizer. Started Dec 2009; status: completed.
02
Drugs
moroctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT00914459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914459.